Evidence map›Paper›PMID 39047808›Full record

ArticleExperimental neurology2024

N

Bernard W Laughlin, M Hoshi Sugiura, Mackenzie Jenkins, Chao-Yin Chen, Kelly L Drew

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Formulation insights into competitive binding of NJournal of pharmaceutical and biomedical analysis · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bernard W LaughlinCenter for Transformative Research in Metabolism, Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK, USA.
M Hoshi SugiuraCenter for Transformative Research in Metabolism, Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK, USA.
Mackenzie JenkinsCenter for Transformative Research in Metabolism, Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK, USA.
Chao-Yin ChenDepartment of Pharmacology, University of California Davis, Davis, California, USA.
Kelly L DrewCenter for Transformative Research in Metabolism, Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK, USA. Electronic address: kdrew@alaska.edu.

Funding

The Administrative CoreP20GM103395 · NIGMS · UNIVERSITY OF ALASKA FAIRBANKS · PI BRIAN M BARNES · 2012 to 2026
$66.1M
Renovation of LARS for Arctic Ground Squirrel BreedingP20GM130443 · NIGMS · UNIVERSITY OF ALASKA FAIRBANKS · PI KELLY L DREW · 2019 to 2026
$16.4M
Development of the first thermolytic to suppress shivering and seizureR41HL135964 · NHLBI · BE COOL PHARMACEUTICS, LLC · PI DREW, KELLY L · 2017 to 2019
$457k
NHLBI NIH HHS R41 HL135964NIGMS NIH HHS P20 GM103395NIGMS NIH HHS P20 GM130443
6 · The paper itself

Abstract

N

Indexed as

AdenosineBuspironeHeart ArrestMeperidineRats, Sprague-DawleyAnimalsBlood PressureHeart RateMaleRatsTheophyllineTreatment OutcomeAdenosineBuspironeMeperidineN(6)-cyclohexyladenosineTheophyllineAdenosine A(1) receptorBlood pressureCardiac arrestTarget temperature managementTherapeutic hypothermia

Identifiers

PMID39047808
PMCPMC12717961

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.